You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myositis Ossificans

Showing 1 - 25 of 118
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Fibrodysplasia Ossificans Progressiva Trial

Not yet recruiting
  • Fibrodysplasia Ossificans Progressiva
    • (no location specified)
    Oct 13, 2023

    Mortality of US Fibrodysplasia Ossificans Progressiva (FOP)

    Active, not recruiting
    • Fibrodysplasia Ossificans Progressiva (FOP)
    • Non-Interventional
    • Tarrytown, New York
      Regeneron
    Sep 26, 2023

    Fibrodysplasia Ossificans Progressiva Trial (Garetosmab, Placebo)

    Recruiting
    • Fibrodysplasia Ossificans Progressiva
    • Nagoya, Aichi, Japan
    • +1 more
    Jan 17, 2023

    Fibrodysplasia Ossificans Progressiva Trial in Paris (Palovarotene)

    Completed
    • Fibrodysplasia Ossificans Progressiva
    • Paris, France
      Hôpital Necker-Enfants Malades, Department of Genetics
    Jul 28, 2022

    Fibrodysplasia Ossificans Progressiva Trial in Osaka (DS-6016a, Placebo)

    Completed
    • Fibrodysplasia Ossificans Progressiva
    • Osaka, Japan
      Medical Corporation Heishinkai OPHAC Hospital
    Aug 2, 2022

    Fibrodysplasia Ossificans Progressiva Trial in Garmisch-Partenkirchen, Amsterdam, London (AZD0530 Difumarate, Matching )

    Recruiting
    • Fibrodysplasia Ossificans Progressiva
    • AZD0530 Difumarate
    • Matching placebo
    • Garmisch-Partenkirchen, Germany
    • +2 more
    Jul 21, 2022

    Fibrodyplasia Ossificans Progressiva (FOP), Heterotopic Ossification (HO) Trial (garetosmab)

    Withdrawn
    • Fibrodyplasia Ossificans Progressiva (FOP)
    • Heterotopic Ossification (HO)
    • (no location specified)
    Oct 25, 2021

    Fibrodysplasia Ossificans Progressiva Trial in Worldwide (Palovarotene)

    Completed
    • Fibrodysplasia Ossificans Progressiva
    • San Francisco, California
    • +15 more
    Dec 16, 2022

    Neurogenic Myositis Ossificans, Neurogenic Para-osteo-arthritis Trial in Garches (CT scan, MRI examination)

    Unknown status
    • Neurogenic Myositis Ossificans
    • Neurogenic Para-osteo-arthritis
    • CT scan
    • MRI examination
    • Garches, Hauts-de-Seine, France
      Service d'Imagerie médicale, Hôpital Raymond Poincaré
    Feb 10, 2021

    Fibrodysplasia Ossificans Progressiva (FOP) Trial in Worldwide (Palovarotene)

    Recruiting
    • Fibrodysplasia Ossificans Progressiva (FOP)
    • San Francisco, California
    • +9 more
    Jul 29, 2022

    Burden of Fibrodysplasia Ossificans Progressiva on Patients and

    Completed
    • Fibrodysplasia Ossificans Progressiva
      • Cambridge, Massachusetts
        Ipsen Central Contact
      May 20, 2021

      Fibrodysplasia Ossificans Progressiva Trial in Worldwide (IPN60130, Placebo)

      Recruiting
      • Fibrodysplasia Ossificans Progressiva
      • San Francisco, California
      • +18 more
      Aug 18, 2022

      Fibrodysplasia Ossificans Progressiva Trial in Worldwide (REGN2477, Matching )

      Completed
      • Fibrodysplasia Ossificans Progressiva
      • Rochester, Minnesota
      • +10 more
      Oct 4, 2021

      Fibrodysplasia Ossificans Progressiva Trial in Cambridge (Palovarotene, midazolam)

      Completed
      • Fibrodysplasia Ossificans Progressiva
      • Cambridge, Massachusetts
        Cambridge Ipsen US
      Apr 1, 2021

      Fibrodysplasia Ossificans Progressiva Trial in France, United Kingdom, United States (Palovarotene, Placebo)

      Completed
      Has Results
      • Fibrodysplasia Ossificans Progressiva
      • San Francisco, California
      • +3 more
      Jan 29, 2021

      Fibrodysplasia Ossificans Progressiva Trial in San Francisco, Philadelphia (Palovarotene)

      Terminated
      Has Results
      • Fibrodysplasia Ossificans Progressiva
      • San Francisco, California
      • +1 more
      Sep 23, 2020

      Fibrodysplasia Ossificans Progressiva (FOP)

      Completed
      • Fibrodysplasia Ossificans Progressiva
        • San Francisco, California
        • +6 more
        Jun 25, 2020

        Inflammatory Myopathy, Idiopathic, Dermatomyositis, Antisynthetase Syndrome Trial in Amsterdam (Immune Globulin Intravenous

        Recruiting
        • Inflammatory Myopathy, Idiopathic
        • +5 more
        • Immune Globulin Intravenous (Human)
        • Placebo
        • Amsterdam, North- Holland, Netherlands
          Department of Neurology, Amsterdam UMC, location AMC
        Apr 14, 2023

        Environmental Risk Factors for Myositis in Military Personnel

        Active, not recruiting
        • Dermatomyositis
        • +3 more
          • Bethesda, Maryland
          • +2 more
          Jan 21, 2023

          Environmental Risk Factors for the Anti-synthetase Syndrome

          Recruiting
          • Myositis
          • +4 more
            • Bethesda, Maryland
            • +1 more
            Jan 7, 2023

            Rheumatoid Arthritis and Myositis Cohort

            Not yet recruiting
            • Rheumatoid Arthritis
            • Myositis
              • (no location specified)
              Nov 21, 2022

              Patients With Inflammatory Myopathies Associated With a Biobank

              Not yet recruiting
              • Inflammatory Myositis
              • +2 more
                • (no location specified)
                Jul 7, 2022

                Myositis, Idiopathic Inflammatory Myopathies Trial in Xiamen (68Ga-FAPI)

                Recruiting
                • Myositis
                • Idiopathic Inflammatory Myopathies
                • Xiamen, Fujian, China
                  The first affiliated hospital of Xiamen University
                Jul 12, 2023

                Inclusion Body Myositis Trial (ABC008)

                Not yet recruiting
                • Inclusion Body Myositis
                • (no location specified)
                Feb 9, 2023

                Adult and Juvenile Myositis

                Recruiting
                • Dermatomyositis
                • +2 more
                  • Bethesda, Maryland
                  • +1 more
                  Jan 20, 2023